Healthcare provider profile · identity verified

Christopher Fox, MD

Sports Medicine · BLUE SPRINGS, MO · NPI 1821417338

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	724	210
Amlodipine Besylate	Amlodipine Besylate	397	111
Levothyroxine Sodium	Levothyroxine Sodium	392	105
Lisinopril	Lisinopril	307	92
Metformin Hcl	Metformin Hcl	253	70
Losartan Potassium	Losartan Potassium	243	68
Pantoprazole Sodium	Pantoprazole Sodium	238	72
Metoprolol Succinate	Metoprolol Succinate	220	64
Omeprazole	Omeprazole	204	59
Rosuvastatin Calcium	Rosuvastatin Calcium	201	62
Gabapentin	Gabapentin	199	65
Trazodone Hcl	Trazodone Hcl	187	62
Hydrochlorothiazide	Hydrochlorothiazide	168	49
Simvastatin	Simvastatin	168	41
Tamsulosin Hcl	Tamsulosin Hcl	163	52
Allopurinol	Allopurinol	142	39
Tramadol Hcl	Tramadol Hcl	127	38
Metformin Hcl Er	Metformin Hcl	102	29
Bupropion Xl	Bupropion Hcl	99	29
Ozempic	Semaglutide	98	23
Albuterol Sulfate Hfa	Albuterol Sulfate	97	34
Meloxicam	Meloxicam	94	35
Furosemide	Furosemide	93	38
Carvedilol	Carvedilol	92	30
Escitalopram Oxalate	Escitalopram Oxalate	91	29
Alendronate Sodium	Alendronate Sodium	84	35
Ezetimibe	Ezetimibe	83	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	80	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	80	20
Fluoxetine Hcl	Fluoxetine Hcl	79	22
Jardiance	Empagliflozin	77	23
Montelukast Sodium	Montelukast Sodium	75	22
Finasteride	Finasteride	72	23
Alprazolam	Alprazolam	71	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	68	18
Eliquis	Apixaban	66	24
Glimepiride	Glimepiride	65	21
Tizanidine Hcl	Tizanidine Hcl	65	31
Potassium Chloride	Potassium Chloride	64	20
Spironolactone	Spironolactone	64	20
Zolpidem Tartrate	Zolpidem Tartrate	64	12
Metoprolol Tartrate	Metoprolol Tartrate	59	16
Pravastatin Sodium	Pravastatin Sodium	58	20
Prednisone	Prednisone	58	49
Sertraline Hcl	Sertraline Hcl	58	21
Fluticasone Propionate	Fluticasone Propionate	56	19
Benazepril Hcl	Benazepril Hcl	48	14
Famotidine	Famotidine	48	15
Fenofibrate	Fenofibrate	48	11
Clopidogrel	Clopidogrel Bisulfate	46	16
Duloxetine Hcl	Duloxetine Hcl	46	16
Citalopram Hbr	Citalopram Hydrobromide	45	13
Pregabalin	Pregabalin	45	suppressed
Trulicity	Dulaglutide	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	21
Lovastatin	Lovastatin	40	11
Mounjaro	Tirzepatide	40	suppressed
Buspirone Hcl	Buspirone Hcl	39	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	37	suppressed
Celecoxib	Celecoxib	37	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	18
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	35	31
Chlorthalidone	Chlorthalidone	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	14
Ipratropium Bromide	Ipratropium Bromide	34	12
Paroxetine Hcl	Paroxetine Hcl	34	13
Warfarin Sodium	Warfarin Sodium	32	suppressed
Atenolol	Atenolol	31	suppressed
Farxiga	Dapagliflozin Propanediol	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	12
Ramipril	Ramipril	31	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	30	29
Solifenacin Succinate	Solifenacin Succinate	30	suppressed
Temazepam	Temazepam	30	suppressed
Terbinafine Hcl	Terbinafine Hcl	30	17
Meclizine Hcl	Meclizine Hcl	28	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	27	suppressed
Irbesartan	Irbesartan	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	20
Glipizide	Glipizide	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Azithromycin	Azithromycin	23	22
Methylprednisolone	Methylprednisolone	23	22
Acyclovir	Acyclovir	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Baclofen	Baclofen	21	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Cholestyramine	Cholestyramine (With Sugar)	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Ventolin Hfa	Albuterol Sulfate	19	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Fluconazole	Fluconazole	17	suppressed
Naproxen	Naproxen	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Valsartan	Valsartan	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Nystatin	Nystatin	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Terazosin Hcl	Terazosin Hcl	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Propranolol Hcl Er	Propranolol Hcl	13	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cimetidine	Cimetidine	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Nabumetone	Nabumetone	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Prenatal Vitamin Plus Low Iron	Pnv,calcium 72/Iron/Folic Acid	12	suppressed
Rizatriptan	Rizatriptan Benzoate	12	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error